Phase 3 Cancer Treatment Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
Cancer Treatment-induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd.235 enrolled2 locationsNCT06456528
Not Yet Recruiting
Phase 3
Prospective, double-blind, randomised study of the efficacy of ketamine for oropharyngeal mucositis pain
Cancer treatment-related oropharyngeal mucositis pain
Monash Health60 enrolled4 locationsACTRN12619000108112
Completed
Phase 3
A study for participants with cancer who experience ongoing nausea, not related to their treatment, despite taking standard and usual medications, that studies the effectiveness of oral methotrimeprazine versus oral haloperidol.
Patients with cancer and nausea not related to anticancer treatment.
Palliative Care Clinical Studies Collaborative (PaCCSC)126 enrolled13 locationsACTRN12615000177550
Completed
Phase 3
A Randomised, double-blind placebo controlled study of subcutaneous ketamine in the management of cancer pain
Pain from cancer or cancer treatment
Flinders University150 enrolled1 locationACTRN12607000501448